Ofer Merimsky
- 5.0 優秀 • 7 レビュー
- 41年の経験
- 認定:
- 所在地: イスラエル, テルアビブ
メリムスキー教授は、スーラスキー医療センターの軟部組織・骨腫瘍科を統括し、1995年より肉腫診療を専門としています。
- パリのギュスターヴ・ルシー研究所にて肉腫治療のフェローシップ研修を修了
- 軟部組織・骨肉腫領域におけるESMOファカルティメンバー
- 41年の経験以上にわたりイスラエル屈指の整形外科腫瘍科を主導
- 腫瘍免疫学および癌性骨疾患に関する研究を発表
- 続きを読む
イスラエルのトップ骨肉腫医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
12
イスラエル
レビュー
14000+
実際の患者より
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示:
メリムスキー教授は、スーラスキー医療センターの軟部組織・骨腫瘍科を統括し、1995年より肉腫診療を専門としています。
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
この医師は小児血液学および腫瘍学の分野での第一人者であり、特に小児の血液疾患および骨癌(肉腫)に特化しています。現在、この医師はテルアビブのSourasky Medical Centerの小児血液腫瘍科のディレクターを務め、Dana Children's Hospitalの上級小児科医でもあります。この医師は骨癌および軟部組織肉腫の治療を調整し、血液凝固障害を管理し、早産児の血液学を監督しています。この医師はイスラエル小児血液腫瘍学会(ISPHO)のメンバーです。
この医師はベングリオン大学を卒業し、Kaplan Medical Centerで小児医学を専門とし、Schneider Children's Medical Centerで小児血液学および腫瘍学をさらに専門としました。追加のトレーニングはイタリアのRizzoli Orthopaedic Instituteで骨および軟部組織の腫瘍学において完了しました。
ジャコブ・ビケルス博士は、腫瘍整形外科と転移性骨疾患の治療に特化した非常に経験豊富な整形外科医です。彼は、イスラエルとアメリカ合衆国の医療センターでインターンシップを行い、イスラエルの腫瘍整形外科センターのシニアドクター、メウヘデト健康サービスのアドバイザー、イチロフ医療センターの転移性骨病変部門の部長を務めるなど、学術的および臨床的な環境での包括的な経験を持っています。主要ポイント:
この医師は、骨肉腫、滑膜肉腫、骨癌の転移、ユーイング肉腫、横紋筋肉腫、骨癌、平滑筋肉腫を含む様々な種類の肉腫の治療を専門としています。この医師は、軍事医学および外科腫瘍学への貢献に対して、Tannenbaum Grant for Excellence in Surgical Oncology や Navigated Sarcoma Surgery Guided Therapeutics GTx Stroble Grant を含む複数の賞を受賞しています。
この医師は、American Musculoskeletal Tumor Society、Connective Tissue Oncology Society、および International Society of Limb Salvage のメンバーです。教育には、Ben-Gurion Medical School での訓練と、整形外科腫瘍学および関節形成術の専門フェローシップが含まれます。
Head of the Department is Dr. Netanel Meusher, a specialist in treatment of bone cancer
Deputy head. of the Pediatric Haematology Department
Prof. Ben Arush treats childhood cancers using therapeutic techniques. Her clinical work revolves around bone marrow transplantation and pediatric hematology. She treats a variety of conditions, including:
The doctor performs procedures such as chemotherapy, immunotherapy, and radiotherapy. She also provides targeted leukemia chemotherapy and radiation for specific solid tumors.
Prof. Ben Arush leads the Department of Pediatric Hematology and Oncology at Rambam Medical Center. She also oversees pediatric care at the Ruth Rappaport Children’s Hospital in Haifa. This role involves supervising oncological treatment for young patients in Israel.
Prof. Ben Arush received international and national honors for her work. These awards include:
The specialist participates in the global oncology research community. Her memberships include:
Chief Physician of the Oncology Center, Oncologist
Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.
He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.
He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.
Orthopedist, Specialist in endoprosthetics
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Israelの142名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか?
治療をガイド
医療訓練を受けた専属コーディネーター






| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 41年の経験 | 骨肉腫 | 1995年より肉腫専門医として先駆的な診療を行い、パリでのフェローシップ研修を修了。イスラエル屈指の骨腫瘍科を主宰し、ESMOの肉腫部門教員を務める。 | イスラエル | から $950 |
Osteosarcoma doctors in Israel are highly qualified specialists. They often hold leadership roles in global oncology faculties and have completed fellowships at institutions like Harvard Medical School or Frances Institut Gustave Roussy. Many specialists are board-certified in oncological orthopedics and pediatric hematology-oncology from both Israel and the USA.
Bookimed Expert Insight: Israeli specialists often dual-specialize in both orthopedic surgery and clinical oncology. For example, Dr. Sternheim Amir at Sourasky holds fellowships in both surgical oncology and joint arthroplasty. This combined expertise allows a single doctor to manage both tumor removal and complex limb reconstruction. Such multi-disciplinary skills are rare and help streamline complex osteosarcoma treatment plans for patients.
Patient Consensus: Patients receiving bone tumor treatment in Israel often highlight the focus on limb-salvage. Parents especially express confidence when working with directors like Dr. Dror Levin, who specialize exclusively in childhood bone cancers. The integration of surgical removal with advanced biological therapies provides a sense of comprehensive care for families.
Israeli specialists often identify inaccuracies in foreign referrals for rare bone cancers like osteosarcoma. Experts such as Dr. Ofer Merimsky and Dr. Eytan Aharon Ben-ami specialize in re-evaluating complex cases. They use advanced pathology and molecular tests to verify tumor types and refine treatment protocols.
Bookimed Expert Insight: Israeli oncology centers often follow a multidisciplinary model where every osteosarcoma diagnosis is reviewed by a tumor board. Specialists like Dr. Eytan Aharon Ben-ami at Sheba even lead early-phase clinical trials. This concentrated expertise helps identify rare tumor variants that general pathologists in other countries might miss.
Patient Consensus: Patients often seek clarification rather than proof of error. They say the value lies in having specialists at centers like Sourasky or Sheba reinterpret earlier findings. They noticed that detailed re-reviews of scans and records often led to faster decision-making for their care.
Israeli oncology specialists perform advanced limb-salvage surgeries to treat osteosarcoma without amputation. Surgeons like Dr. Jakov Bikels and Dr. Sternheim Amir use endoprosthetics – special internal implants – to replace bone removed during tumor resection, preserving both the limb and its function.
Bookimed Expert Insight: Israeli hospitals like Sourasky (Ichilov) stand out because they centralize all bone tumor specialists within a single facility. This allows orthopedic surgeons to work alongside pediatric oncologists in the same theater. Patients benefit from this coordination, as specialized units like the one led by Dr. Netanel Meushar at Rambam focus exclusively on complex osteosarcoma cases.
Patient Consensus: Patients often express relief at finding centers that prioritize reconstruction over amputation. Many noticed that doctors focus on saving as much natural mobility as possible using custom implants.
Israeli doctors prioritize high-dose chemotherapy combined with limb-sparing surgery to treat osteosarcoma and prevent metastasis. Leading specialists like Dr. Eytan Aharon Ben-ami and Prof. Ofer Merimsky use personalized protocols. These often include targeted therapies and phase I clinical trials to improve outcomes for complex bone tumors.
Bookimed Expert Insight: Israeli sarcoma specialists often bridge the gap between medical oncology and orthopedic surgery. For example, Dr. Sternheim Amir and Dr. Yuri Goldes specialize in both tumor removal and advanced reconstruction. This dual expertise allows them to adjust chemotherapy timing more precisely. This coordination ensures that pre-operative treatment effectively prepares the bone for innovative limb-salvage procedures.
Patient Consensus: Patients describe a rigorous journey involving four months of chemotherapy before surgery followed by four additional months. They often note that managing side effects like nausea is a central part of the hospital's supportive care during the year-long treatment process.
Israeli doctors use radiation therapy as a secondary tool within integrated protocols for osteosarcoma, focusing on cases where surgery cannot achieve clear margins. Top specialists, such as Dr. Ofer Merimsky at Sourasky Medical Center, utilize advanced targeting to deliver high doses to tumors in complex locations like the spine or pelvis.
Bookimed Expert Insight: Israeli oncology centers often centralize sarcoma care under specialists with unique international training. For example, Dr. Eytan Aharon Ben-ami at Sheba Medical Center completed a specialized sarcoma fellowship at Harvard. This level of focused expertise allows doctors to integrate early-phase clinical trials and molecular research directly into radiation planning, which is not standard at every hospital.
Patient Consensus: Patients describe bone cancer treatment as an unusually demanding and aggressive journey. Many emphasize that radiation is often framed as a secondary step to surgery in their multi-stage plan. Those who felt most at ease sought second opinions to confirm the timing and sequence of their radiation sessions.